Blood Coagulation Disorders  >>  Optivate (factor VIII/von Willebrand factor)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Optivate (factor VIII/von Willebrand factor) / Bio Products Lab
NCT02250508: A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.

Completed
2
RoW
Optivate® (Human Coagulation Factor VIII), Haemate P® (Human Coagulation Factor VIII)
Bio Products Laboratory
vonWillebrand's Disease
06/05
 

Download Options